Loading...

Table of Content

    15 February 2023, Volume 18 Issue 2 Previous Issue    Next Issue
    For Selected: Toggle Thumbnails
    c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseases
    Daniela A. Gutiérrez, América Chandía-Cristi, María José Yáñez, Silvana Zanlungo, Alejandra R. Álvarez
    2023, 18 (2):  237-243.  doi: 10.4103/1673-5374.346540
    Abstract ( 180 )   PDF (2099KB) ( 140 )   Save
    Our ability to learn and remember depends on the active formation, remodeling, and elimination of synapses. Thus, the development and growth of synapses as well as their weakening and elimination are essential for neuronal rewiring. The structural reorganization of synaptic complexes, changes in actin cytoskeleton and organelle dynamics, as well as modulation of gene expression, determine synaptic plasticity. It has been proposed that dysregulation of these key synaptic homeostatic processes underlies the synaptic dysfunction observed in many neurodegenerative diseases. Much is known about downstream signaling of activated N-methyl-D-aspartate and α-amino-3-hydroxy-5-methyl-4-isoazolepropionate receptors; however, other signaling pathways can also contribute to synaptic plasticity and long-lasting changes in learning and memory. The non-receptor tyrosine kinase c-Abl (ABL1) is a key signal transducer of intra and extracellular signals, and it shuttles between the cytoplasm and the nucleus. This review focuses on c-Abl and its synaptic and neuronal functions. Here, we discuss the evidence showing that the activation of c-Abl can be detrimental to neurons, promoting the development of neurodegenerative diseases. Nevertheless, c-Abl activity seems to be in a pivotal balance between healthy synaptic plasticity, regulating dendritic spines remodeling and gene expression after cognitive training, and synaptic dysfunction and loss in neurodegenerative diseases. Thus, c-Abl genetic ablation not only improves learning and memory and modulates the brain genetic program of trained mice, but its absence provides dendritic spines resiliency against damage. Therefore, the present review has been designed to elucidate the common links between c-Abl regulation of structural changes that involve the actin cytoskeleton and organelles dynamics, and the transcriptional program activated during synaptic plasticity. By summarizing the recent discoveries on c-Abl functions, we aim to provide an overview of how its inhibition could be a potentially fruitful treatment to improve degenerative outcomes and delay memory loss.
    Related Articles | Metrics
    The mechanism and relevant mediators associated with neuronal apoptosis and potential therapeutic targets in subarachnoid hemorrhage
    Qi Tian, Sheng Liu, Shou-Meng Han, Wei Zhang, Xian-Yao Qin, Jun-Hui Chen, Cheng-Li Liu, Yu-Jia Guo, Ming-Chang Li
    2023, 18 (2):  244-252.  doi: 10.4103/1673-5374.346542
    Abstract ( 142 )   PDF (16398KB) ( 66 )   Save
    blood-brain barrier; mechanism; mediators; neuronal apoptosis; pathways; subarachnoid hemorrhage; targets; treatmentSubarachnoid hemorrhage (SAH) is a dominant cause of death and disability worldwide. A sharp increase in intracranial pressure after SAH leads to a reduction in cerebral perfusion and insufficient blood supply for neurons, which subsequently promotes a series of pathophysiological responses leading to neuronal death. Many previous experimental studies have reported that excitotoxicity, mitochondrial death pathways, the release of free radicals, protein misfolding, apoptosis, necrosis, autophagy, and inflammation are involved solely or in combination in this disorder. Among them, irreversible neuronal apoptosis plays a key role in both short- and long-term prognoses after SAH. Neuronal apoptosis occurs through multiple pathways including extrinsic, mitochondrial, endoplasmic reticulum, p53 and oxidative stress. Meanwhile, a large number of blood contents enter the subarachnoid space after SAH, and the secondary metabolites, including oxygenated hemoglobin and heme, further aggravate the destruction of the blood-brain barrier and vasogenic and cytotoxic brain edema, causing early brain injury and delayed cerebral ischemia, and ultimately increasing neuronal apoptosis. Even there is no clear and effective therapeutic strategy for SAH thus far, but by understanding apoptosis, we might excavate new ideas and approaches, as targeting the upstream and downstream molecules of apoptosis-related pathways shows promise in the treatment of SAH. In this review, we summarize the existing evidence on molecules and related drugs or molecules involved in the apoptotic pathway after SAH, which provides a possible target or new strategy for the treatment of SAH.
    Related Articles | Metrics
    Brain and spinal cord trauma: what we know about the therapeutic potential of insulin growth factor 1 gene therapy
    María Jose Bellini, Florencia Labombarda
    2023, 18 (2):  253-257.  doi: 10.4103/1673-5374.343902
    Abstract ( 136 )   PDF (419KB) ( 88 )   Save
    Although little attention has been paid to cognitive and emotional dysfunctions observed in patients after spinal cord injury, several reports have described impairments in cognitive abilities. Our group also has contributed significantly to the study of cognitive impairments in a rat model of spinal cord injury. These findings are very significant because they demonstrate that cognitive and mood deficits are not induced by lifestyle changes, drugs of abuse, and combined medication. They are related to changes in brain structures involved in cognition and emotion, such as the hippocampus. Chronic spinal cord injury decreases neurogenesis, enhances glial reactivity leading to hippocampal neuroinflammation, and triggers cognitive deficits. These brain distal abnormalities are recently called tertiary damage. Given that there is no treatment for Tertiary Damage, insulin growth factor 1 gene therapy emerges as a good candidate. Insulin growth factor 1 gene therapy recovers neurogenesis and induces the polarization from pro-inflammatory towards anti-inflammatory microglial phenotypes, which represents a potential strategy to treat the neuroinflammation that supports tertiary damage. Insulin growth factor 1 gene therapy can be extended to other central nervous system pathologies such as traumatic brain injury where the neuroinflammatory component is crucial. Insulin growth factor 1 gene therapy could emerge as a new therapeutic strategy for treating traumatic brain injury and spinal cord injury.  
    Related Articles | Metrics
    Functions and mechanisms of cytosolic phospholipase A2 in central nervous system trauma
    Hao-Jie Zhang, Yi-Tuo Chen, Xin-Li Hu, Wan-Ta Cai, Xiang-Yang Wang, Wen-Fei Ni, Kai-Liang Zhou
    2023, 18 (2):  258-266.  doi: 10.4103/1673-5374.346460
    Abstract ( 183 )   PDF (11297KB) ( 40 )   Save
    Central nervous system (CNS) trauma, including traumatic brain injury and spinal cord injury, has a high rate of disability and mortality, and effective treatment is currently lacking. Previous studies have revealed that neural inflammation plays a vital role in CNS trauma. As the initial enzyme in neuroinflammation, cytosolic phospholipase A2 (cPLA2) can hydrolyze membranous phosphatides at the sn-2 position in a preferential way to release lysophospholipids and ω3-polyunsaturated fatty acid dominated by arachidonic acid, thereby inducing secondary injuries. Although there is substantial fresh knowledge pertaining to cPLA2, in-depth comprehension of how cPLA2 participates in CNS trauma and the potential methods to ameliorate the clinical results after CNS trauma are still insufficient. The present review summarizes the latest understanding of how cPLA2 participates in CNS trauma, highlighting novel findings pertaining to how cPLA2 activation initiates the potential mechanisms specifically, neuroinflammation, lysosome membrane functions, and autophagy activity, that damage the CNS after trauma. Moreover, we focused on testing a variety of drugs capable of inhibiting cPLA2 or the upstream pathway, and we explored how those agents might be utilized as treatments to improve the results following CNS trauma. This review aimed to effectively understand the mechanism of cPLA2 activation and its role in the pathophysiological processes of CNS trauma and provide clarification and a new referential framework for future research.
    Related Articles | Metrics
    Microglia depletion as a therapeutic strategy: friend or foe in multiple sclerosis models?
    Victoria Sofia Berenice Wies Mancini, Anabella Ayelen Di Pietro, Laura Andrea Pasquini
    2023, 18 (2):  267-272.  doi: 10.4103/1673-5374.346538
    Abstract ( 171 )   PDF (1736KB) ( 96 )   Save
    Multiple sclerosis is a chronic central nervous system demyelinating disease whose onset and progression are driven by a combination of immune dysregulation, genetic predisposition, and environmental factors. The activation of microglia and astrocytes is a key player in multiple sclerosis immunopathology, playing specific roles associated with anatomical location and phase of the disease and controlling demyelination and neurodegeneration. Even though reactive microglia can damage tissue and heighten deleterious effects and neurodegeneration, activated microglia also perform neuroprotective functions such as debris phagocytosis and growth factor secretion. Astrocytes can be activated into pro-inflammatory phenotype A1 through a mechanism mediated by activated neuroinflammatory microglia, which could also mediate neurodegeneration. This A1 phenotype inhibits oligodendrocyte proliferation and differentiation and is toxic to both oligodendrocytes and neurons. However, astroglial activation into phenotype A2 may also take place in response to neurodegeneration and as a protective mechanism. A variety of animal models mimicking specific multiple sclerosis features and the associated pathophysiological processes have helped establish the cascades of events that lead to the initiation, progression, and resolution of the disease. The colony-stimulating factor-1 receptor is expressed by myeloid lineage cells such as peripheral monocytes and macrophages and central nervous system microglia. Importantly, as microglia development and survival critically rely on colony-stimulating factor-1 receptor signaling, colony-stimulating factor-1 receptor inhibition can almost completely eliminate microglia from the brain. In this context, the present review discusses the impact of microglial depletion through colony-stimulating factor-1 receptor inhibition on demyelination, neurodegeneration, astroglial activation, and behavior in different multiple sclerosis models, highlighting the diversity of microglial effects on the progression of demyelinating diseases and the strengths and weaknesses of microglial modulation in therapy design. 
    Related Articles | Metrics
    Cre-recombinase systems for induction of neuron-specific knockout models: a guide for biomedical researchers
    Tetiana Shcholok, Eftekhar Eftekharpour
    2023, 18 (2):  273-279.  doi: 10.4103/1673-5374.346541
    Abstract ( 350 )   PDF (4372KB) ( 136 )   Save
    Gene deletion has been a valuable tool for unraveling the mysteries of molecular biology. Early approaches included gene trapping and gene targetting to disrupt or delete a gene randomly or at a specific location, respectively. Using these technologies in mouse embryos led to the generation of mouse knockout models and many scientific discoveries. The efficacy and specificity of these approaches have significantly increased with the advent of new technology such as clustered regularly interspaced short palindromic repeats for targetted gene deletion. However, several limitations including unwanted off-target gene deletion have hindered their widespread use in the field. Cre-recombinase technology has provided additional capacity for cell-specific gene deletion. In this review, we provide a summary of currently available literature on the application of this system for targetted deletion of neuronal genes. This article has been constructed to provide some background information for the new trainees on the mechanism and to provide necessary information for the design, and application of the Cre-recombinase system through reviewing the most frequent promoters that are currently available for genetic manipulation of neurons. We additionally will provide a summary of the latest technological developments that can be used for targeting neurons. This may also serve as a general guide for the selection of appropriate models for biomedical research.
    Related Articles | Metrics
    Prenatal programing of motivated behaviors: can innate immunity prime behavior?
    Larisa Montalvo-Martínez, Gabriela Cruz-Carrillo, Roger Maldonado-Ruiz, Luis A. Trujillo-Villarreal, Eduardo A. Garza-Villarreal, Alberto Camacho-Morales
    2023, 18 (2):  280-283.  doi: 10.4103/1673-5374.346475
    Abstract ( 134 )   PDF (1051KB) ( 83 )   Save
    Prenatal programming during pregnancy sets physiological outcomes in the offspring by integrating external or internal stimuli. Accordingly, pregnancy is an important stage of physiological adaptations to the environment where the fetus becomes exposed and adapted to the maternal milieu. Maternal exposure to high-energy dense diets can affect motivated behavior in the offspring leading to addiction and impaired sociability. A high-energy dense exposure also increases the pro-inflammatory cytokines profile in plasma and brain and favors microglia activation in the offspring. While still under investigation, prenatal exposure to high-energy dense diets promotes structural abnormalities in selective brain regions regulating motivation and social behavior in the offspring. The current review addresses the role of energy-dense foods programming central and peripheral inflammatory profiles during embryonic development and its effect on motivated behavior in the offspring. We provide preclinical and clinical evidence that supports the contribution of prenatal programming in shaping immune profiles that favor structural and brain circuit disruption leading to aberrant motivated behaviors after birth. We hope this minireview encourages future research on novel insights into the mechanisms underlying maternal programming of motivated behavior by central immune networks.
    Related Articles | Metrics
    Safety, immunogenicity, efficacy, and acceptability of COVID-19 vaccination in people with multiple sclerosis: a narrative review
    Fioravante Capone, Mariagrazia Rossi, Alessandro Cruciani, Francesco Motolese, Fabio Pilato, Vincenzo Di Lazzaro
    2023, 18 (2):  284-288.  doi: 10.4103/1673-5374.346539
    Abstract ( 158 )   PDF (421KB) ( 129 )   Save
    In the last two years, a new severe acute respiratory syndrome coronavirus (SARS-CoV) infection has spread worldwide leading to the death of millions. Vaccination represents the key factor in the global strategy against this pandemic, but it also poses several problems, especially for vulnerable people such as patients with multiple sclerosis. In this review, we have briefly summarized the main findings of the safety, efficacy, and acceptability of Coronavirus Disease 2019 (COVID-19) vaccination for multiple sclerosis patients. Although the acceptability of COVID-19 vaccines has progressively increased in the last year, a small but significant part of patients with multiple sclerosis still has relevant concerns about vaccination that make them hesitant about receiving the COVID-19 vaccine. Overall, available data suggest that the COVID-19 vaccination is safe and effective in multiple sclerosis patients, even though some pharmacological treatments such as anti-CD20 therapies or sphingosine l-phosphate receptor modulators can reduce the immune response to vaccination. Accordingly, COVID-19 vaccination should be strongly recommended for people with multiple sclerosis and, in patients treated with anti-CD20 therapies and sphingosine l-phosphate receptor modulators, and clinicians should evaluate the appropriate timing for vaccine administration. Further studies are necessary to understand the role of cellular immunity in COVID-19 vaccination and the possible usefulness of booster jabs. On the other hand, it is mandatory to learn more about the reasons why people refuse vaccination. This would help to design a more effective communication campaign aimed at increasing vaccination coverage among vulnerable people.
    Related Articles | Metrics
    Simulating traumatic brain injury in vitro: developing high throughput models to test biomaterial based therapies
    Raja Haseeb Basit, Jessica Wiseman, Farhana Chowdhury, Divya Maitreyi Chari
    2023, 18 (2):  289-292.  doi: 10.4103/1673-5374.346465
    Abstract ( 132 )   PDF (1379KB) ( 56 )   Save
    Traumatic brain injuries are serious clinical incidents associated with some of the poorest outcomes in neurological practice. Coupled with the limited regenerative capacity of the brain, this has significant implications for patients, carers, and healthcare systems, and the requirement for life-long care in some cases. Clinical treatment currently focuses on limiting the initial neural damage with long-term care/support from multidisciplinary teams. Therapies targeting neuroprotection and neural regeneration are not currently available but are the focus of intensive research. Biomaterial-based interventions are gaining popularity for a range of applications including biomolecule and drug delivery, and to function as cellular scaffolds. Experimental investigations into the development of such novel therapeutics for traumatic brain injury will be critically underpinned by the availability of appropriate high throughput, facile, ethically viable, and pathomimetic biological model systems. This represents a significant challenge for researchers given the pathological complexity of traumatic brain injury. Specifically, there is a concerted post-injury response mounted by multiple neural cell types which includes microglial activation and astroglial scarring with the expression of a range of growth inhibitory molecules and cytokines in the lesion environment. Here, we review common models used for the study of traumatic brain injury (ranging from live animal models to in vitro systems), focusing on penetrating traumatic brain injury models. We discuss their relative advantages and drawbacks for the developmental testing of biomaterial-based therapies.
    Related Articles | Metrics
    Mortalin/Hspa9 involvement and therapeutic perspective in Parkinson’s disease
    Baptiste Texier, Morgane Prime, Djamaa Atamena, Pascale Belenguer, Marion Szelechowski
    2023, 18 (2):  293-298.  doi: 10.4103/1673-5374.346487
    Abstract ( 222 )   PDF (746KB) ( 88 )   Save
    By controlling the proper folding of proteins imported into mitochondria and ensuring crosstalk between the reticulum and mitochondria to modulate intracellular calcium fluxes, Mortalin is a chaperone protein that plays crucial roles in neuronal homeostasis and activity. However, its expression and stability are strongly modified in response to cellular stresses, in particular upon altered oxidative conditions during neurodegeneration. Here, we report and discuss the abundant literature that has highlighted its contribution to the pathophysiology of Parkinson’s disease, as well as its therapeutic and prognostic potential in this still incurable pathology.
    Related Articles | Metrics
    The potential of gene therapies for spinal cord injury repair: a systematic review and meta-analysis of pre-clinical studies
    Catriona J. Cunningham, Mindaugas Viskontas, Krzysztof Janowicz, Yasmin Sani, Malin E. Håkansson, Anastasia Heidari, Wenlong Huang, Xuenong Bo
    2023, 18 (2):  299-305.  doi: 10.4103/1673-5374.347941
    Abstract ( 185 )   PDF (2859KB) ( 132 )   Save
    Currently, there is no cure for traumatic spinal cord injury but one therapeutic approach showing promise is gene therapy. In this systematic review and meta-analysis, we aim to assess the efficacy of gene therapies in pre-clinical models of spinal cord injury and the risk of bias. In this meta-analysis, registered at PROSPERO (Registration ID: CRD42020185008), we identified relevant controlled in vivo studies published in English by searching the PubMed, Web of Science, and Embase databases. No restrictions of the year of publication were applied and the last literature search was conducted on August 3, 2020. We then conducted a random-effects meta-analysis using the restricted maximum likelihood estimator. A total of 71 studies met our inclusion criteria and were included in the systematic review. Our results showed that overall, gene therapies were associated with improvements in locomotor score (standardized mean difference [SMD]: 2.07, 95% confidence interval [CI]: 1.68–2.47, Tau2 = 2.13, I2 = 83.6%) and axonal regrowth (SMD: 2.78, 95% CI: 1.92–3.65, Tau2 = 4.13, I2 = 85.5%). There was significant asymmetry in the funnel plots of both outcome measures indicating the presence of publication bias. We used a modified CAMARADES (Collaborative Approach to Meta-Analysis and Review of Animal Data in Experimental Studies) checklist to assess the risk of bias, finding that the median score was 4 (IQR: 3–5). In particular, reports of allocation concealment and sample size calculations were lacking. In conclusion, gene therapies are showing promise as therapies for spinal cord injury repair, but there is no consensus on which gene or genes should be targeted.
    Related Articles | Metrics
    The Wnt/β-catenin signaling: a multifunctional target for neuroprotective and regenerative strategies in Parkinson’s disease
    Annalucia Serafino, Mauro Cozzolino
    2023, 18 (2):  306-308.  doi: 10.4103/1673-5374.343908
    Abstract ( 136 )   PDF (1509KB) ( 82 )   Save
    Parkinson’s disease (PD) is the most frequent movement disorder and the second most prevalent age-related neurodegenerative disease (ND) worldwide. From the clinical point of view, it is characterized by severe motor complications, including uncontrollable resting tremors, rigidity, bradykinesia, and postural instability. These motor symptoms are caused by the selective and progressive degeneration of midbrain dopaminergic neurons in the subtantia nigra pars compacta and their striatal projections (Kalia and Lang, 2015), which leads to a substantial reduction in dopamine production. Motor features of PD are associated with the accumulation of pathological aggregates of α-synuclein into Lewy bodies, considered the most typical hallmarks of the disease. Non­motor symptoms, including the progressive impairment of cognitive, autonomic, and mood functions, are additional PD-associated clinical complications, consequent to damage in other regions of the central and peripheral nervous system (Kalia and Lang, 2015; Schapira et al., 2017). Indeed, besides dopaminergic neuron degeneration, it is now clear that dysfunction of glial components and other kinds of neurons also participate in PD pathogenesis and progression.
    Related Articles | Metrics
    Approaches to quantify axonal morphology for the analysis of axonal degeneration
    Alex Palumbo, Marietta Zille
    2023, 18 (2):  309-310.  doi: 10.4103/1673-5374.343904
    Abstract ( 210 )   PDF (4437KB) ( 74 )   Save
    Morphological hallmarks of axonal degeneration (AxD): Axons transmit signals from one neuron to another and are crucial for the proper communication in the nervous system. Therefore, the disintegration of axons, a process named AxD, has detrimental consequences and plays a key role in many neurological diseases.
    Related Articles | Metrics
    MicroRNA-based targeting of the Rho/ROCK pathway in therapeutic strategies after spinal cord injury
    Tetsu Kimura, Yuta Horikoshi
    2023, 18 (2):  311-312.  doi: 10.4103/1673-5374.346480
    Abstract ( 151 )   PDF (1336KB) ( 90 )   Save
    Spinal cord injury (SCI) is one of the leading causes of disability and is a devastating condition that requires long-term care, reduces social productivity, and gives an immense emotional burden on patients and their families. SCI frequently occurs due to traffic accidents, falls, slips, violence, sports, and medical accidents in today’s society. The initial mechanical damage triggers a secondary injury cascade that induces more intractable damage (Silva et al., 2014). Secondary injury mechanisms have been postulated, including neuronal apoptosis, inflammation, oxidative stress, and excitotoxicity. The failure of axons and nerves to regenerate may contribute to the difficulty in recovering function after spinal cord injury. Therefore, suppressing axon growth inhibition or encouraging axon regeneration must be beneficial for the treatment of SCI. This article will discuss the involvement of microRNAs (miRNAs), a non-coding RNA that affects various physiological and pathological conditions, in the Rho/Rho-kinase (ROCK) pathway in SCI pathogenesis, especially in axon regeneration, and its therapeutic application.
    Related Articles | Metrics
    Advances in quantitative analysis of astrocytes using machine learning
    Demetrio Labate, Cihan Kayasandik
    2023, 18 (2):  313-314.  doi: 10.4103/1673-5374.346474
    Abstract ( 152 )   PDF (3857KB) ( 124 )   Save
    Astrocytes, a subtype of glial cells, are star-shaped cells that are involved in the homeostasis and blood flow control of the central nervous system (CNS). They are known to provide structural and functional support to neurons, including the regulation of neuronal activation through extracellular ion concentrations, the regulation of energy dynamics in the brain through the transfer of lactate to neurons, and the modulation of synaptic transmission via the release of neurotransmitters such as glutamate and adenosine triphosphate. In addition, astrocytes play a critical role in neuronal reconstruction after brain injury, including neurogenesis, synaptogenesis, angiogenesis, repair of the blood-brain barrier, and glial scar formation after traumatic brain injury (Zhou et al., 2020). The multifunctional role of astrocytes in the CNS with tasks requiring close contact with their targets is reflected by their morphological complexity, with processes and ramifications occurring over multiple scales where interactions are plastic and can change depending on the physiological conditions. Another major feature of astrocytes is reactive astrogliosis, a process occurring in response to traumatic brain injury, neurological diseases, or infection which involves substantial morphological alterations and is often accompanied by molecular, cytoskeletal, and functional changes that ultimately play a key role in the disease outcome (Schiweck et al., 2018). Because morphological changes in astrocytes correlate so significantly with brain injury and the development of pathologies of the CNS, there is a major interest in methods to reliably detect and accurately quantify such morphological alterations. We review below the recent progress in the quantitative analysis of images of astrocytes. We remark that, while our discussion is focused on astrocytes, the same methods discussed below can be applied to other types of complex glial cells.
    Related Articles | Metrics
    Synaptopathy in CHMP2B frontotemporal dementia highlights the synaptic vesicle cycle as a therapeutic target
    Miranda Robbins, Emma L. Clayton
    2023, 18 (2):  315-316.  doi: 10.4103/1673-5374.343905
    Abstract ( 130 )   PDF (3943KB) ( 75 )   Save
    Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are both devastating neurodegenerative conditions. Despite affecting different regions of the nervous system (FTD affecting primarily the frontal and temporal lobes, whilst ALS presents with motor neuron loss), there is significant overlap between these conditions in terms of genetics, pathology, and disease mechanisms, and they are therefore often grouped as a spectrum of symptoms under the heading FTD/ALS (Abramzon et al., 2020). Significantly, there is currently no cure for ALS or FTD. However, recent mechanistic insight points to a novel pathway to target for potential therapeutic intervention.
    Related Articles | Metrics
    The role of mitochondria in the recovery of neurons after injury
    Taylor McElroy, Rola S. Zeidan, Laxmi Rathor, Sung Min Han, Rui Xiao
    2023, 18 (2):  317-318.  doi: 10.4103/1673-5374.343907
    Abstract ( 325 )   PDF (569KB) ( 145 )   Save
    Mitochondria are well characterized by their fundamental functions in regulating cellular homeostasis, including energy and iron metabolism. These functions are essential in neurons with high metabolic demands and elongated neuronal processes. Mitochondria dynamically change morphology, localization, and activity to match neurons’ spatial and temporal demands. Mitochondrial dysfunctions have been associated with many neurological disorders. Recent studies highlight that mitochondria also act as central regulators of the neuronal response to injury. Here, we discuss important findings that support the critical regulation of mitochondrial dynamics, energy metabolism, and iron homeostasis in the repair of damaged neurons.
    Related Articles | Metrics
    Turning up the NAD+-mitophagy axis to treat Alzheimer’s disease
    Evandro F. Fang, Alexander Anisimov
    2023, 18 (2):  319.  doi: 10.4103/1673-5374.346472
    Abstract ( 144 )   PDF (1139KB) ( 103 )   Save
    The increase in the prevalence of individuals with Alzheimer’s disease (AD) combined with the lack of a cure calls for the development of novel therapies against AD (Canter et al., 2016). The key disease-defining pathological features of AD are the accumulation of extracellular amyloid-beta (Aβ) plaques (accompanied by increasing intracellular Aβ1–42) and higher intracellular neurofibrillary tangles, comprised mostly of hyperphosphorylated tau protein/pTau (Goedert, 2015; Hardy, 2017). It is evident that the elderly are more predisposed to develop AD, and thus aging is considered to be the primary risk factor for AD. By extrapolation, strategies that delay aging may also slow down (if not stop) AD.
    Related Articles | Metrics
    Kainate receptors in the CA2 region of the hippocampus
    Yuniesky Andrade-Talavera, Antonio Rodríguez-Moreno
    2023, 18 (2):  320-321.  doi: 10.4103/1673-5374.343912
    Abstract ( 134 )   PDF (5775KB) ( 59 )   Save
    The hippocampus is involved in important brain functions such as learning and memory, spatial navigation, fear processing, and social behavior (Dudek et al, 2016). The most prominent areas of the hippocampus are typically denoted as the dentate gyrus and the three areas of the cornu ammonis (CA1, CA2, and CA3). Discovered by Lorente de Nó (1934), the CA2 region of the hippocampus is a relatively small area interposed between CA3 and CA1 that forms the nexus linking the input of the entorhinal cortex to the output of CA1 (Chevaleyre and Siegelbaum, 2010). Although little is known about the function of CA2 in detail (Hitti and Siegelbaum, 2014; Dudek et al., 2016), there is currently increasing interest in its physiology and cumulative evidence indicates that this region has important and unique properties as it participates in engram formation, neurodegeneration and information processing (Hainmueller and Bartos, 2018; Pang et al., 2019; Middleton and Mchugh, 2020; Lehr et al., 2021). Recent discoveries have revealed that CA2 is involved in the formation of social and spatio/temporal memories (Hitti and Siegelbaum, 2014; Dudek et al., 2016). In addition, the CA2 network seems to play a critical role in balancing levels of excitation and inhibition in the hippocampus (Boehringer et al., 2017). Importantly, excitation/inhibition imbalances have been implicated in the diverse brain and neurodevelopmental disorders. 
    Related Articles | Metrics
    Understanding the timing of brain injury in fetal growth restriction: lessons from a model of spontaneous growth restriction in piglets
    Hannah Musco, Julie A. Wixey
    2023, 18 (2):  322-323.  doi: 10.4103/1673-5374.343909
    Abstract ( 131 )   PDF (275KB) ( 44 )   Save
    Fetal growth restriction (FGR) is one of the most common contributors to increased risk of mortality in the fetal/neonatal period and long-term morbidity in the infant (Malhotra et al., 2019). FGR can arise from many pathophysiological processes associated with maternal, fetal, genetic, or placental compromise; however, placental insufficiency is the most common cause of FGR. Placental insufficiency during pregnancy results in chronic fetal hypoxia where a lack of oxygen and nutrients supply to the developing fetus impacts normal development of the fetus. The fetal brain is especially vulnerable to FGR conditions. Neuronal and white matter injury are major pathophysiological features of FGR with clinical imaging studies identifying lower grey and white matter complexity in FGR preterm infants compared with both preterm and term infants (Esteban et al., 2010). These structural abnormalities remain at one year of age and are associated with neurodevelopmental disabilities (Esteban et al., 2010). Unfortunately, there are currently no interventions for the prevention or treatment of these structural brain alterations in the FGR infant. Determining mechanisms of brain injury and the timing of these injury processes (i.e., when they are initiated) would greatly assist with the identification and timing of treatment options for FGR to improve brain outcomes. 
    Related Articles | Metrics
    Acid-sensing ion channel 1a: a novel target in Alzheimer’s disease?
    Dalila Mango, Robert Nisticò
    2023, 18 (2):  324.  doi: 10.4103/1673-5374.346479
    Abstract ( 108 )   PDF (793KB) ( 69 )   Save
    Alzheimer’s disease (AD) represents the most common form of dementia and is characterized by a progressive decline of cognitive functions. Complex multifactorial processes underlie AD pathophysiology, including amyloid-beta (Aβ) toxicity, tau protein hyperphosphorylation, synaptic dysfunction, oxidative stress, and neuroinflammation (Ju and Tam, 2022).
    Related Articles | Metrics
    Schwann cell extracellular vesicles: judging a book by its cover
    Steven L. Gonias, Wendy M. Campana
    2023, 18 (2):  325-326.  doi: 10.4103/1673-5374.346478
    Abstract ( 120 )   PDF (1084KB) ( 49 )   Save
    Schwann cells (SCs) are essential in the development of the peripheral nervous system (PNS), in PNS injury, and the aging PNS. SCs comprise greater than 90% of the nucleated cells in peripheral nerves (Campana, 2007). Myelinating SCs insulate large-diameter axons, forming a 1:1 relationship and promoting saltatory conduction of axonal action potentials. Non-myelinating SCs ensheathe clusters of smaller diameter axons in Remak bundles. Both types of SCs provide essential metabolic and trophic support to axons, which is essential for maintaining axon integrity in healthy peripheral nerves.
    Related Articles | Metrics
    (Phospho)creatine: the reserve and merry-go-round of brain energetics
    Hong-Ru Chen, Ton DeGrauw, Chia-Yi Kuan
    2023, 18 (2):  327-328.  doi: 10.4103/1673-5374.346470
    Abstract ( 156 )   PDF (1716KB) ( 58 )   Save
    Creatine transporter (CrT)-deficiency, the most common form of the cerebral creatine deficiency syndromes, causes cognition impairments and severe reduction of the brain creatine (Cr) and phosphocreatine (PCr) levels, and responds poorly to oral Cr supplement as a treatment option. The causes of cognitive impairments in CrT-deficient children remain unclear. We recently use gene-targeting to create a mouse model of CrT-deficiency to assess the impacts of Cr/PCr deficiency on brain energetics and stress-adaptation responses (Chen et al., 2021). We found that Cr/PCr-deficiency impairs the development of dendritic spines and synapses, skews the balance of mechanistic target of rapamycin (mTOR) and autophagy signaling towards catabolism, and elevates the sensitivity to external stress, including ischemia or hypoxia, to cause greater brain injury. Notably, intranasal delivery of Cr after cerebral ischemia raises the brain Cr/PCr levels and reduces the infarct size in CrT-null mice, despite Cr itself lacking a high-energy phosphoryl group. These findings highlight a critical role of Cr/PCr for maintaining brain energetics and suggest potential therapies of CrT-deficiency.
    Related Articles | Metrics
    Perspective on inflammatory cytokines in open spinal dysraphism
    Friederike Knerlich-Lukoschus
    2023, 18 (2):  329-330.  doi: 10.4103/1673-5374.343901
    Abstract ( 121 )   PDF (1177KB) ( 20 )   Save
    Myelomeningocele (MMC) is a severe form of spinal dysraphism. Due to the failure of neural tube closure during early embryonic development, the affected part of the spinal cord is left open like a book at the back of the affected child. This malformed part of the spinal cord is not covered by its protective mesodermal and ectodermal derived layers. Consequently, the exposed neural tissue (i.e., the neural placode) is prone to injury during further intra-uterine development. Former investigations in sheep MMC models and ultrasound examinations in human fetuses demonstrated progressively decreased limb function during the later fetal course (Stiefel and Meuli, 2007). As a possible morphological correlate, Stiefel and Meuli (2007) demonstrated progressive tissue destruction of the initially intact appearing unfolded neural placode in curly tail/loop tail mouse fetuses. These observations were consistent with the hypothesis of secondary damage of the neural placode (so-called “second hit hypothesis”) (Heffez et al., 1990). According to this hypothesis, the “first hit” is considered the primary structural defect, which is due to faulty developmental processes. The size and location of the spinal cord abnormality within the spinal axis are important in determining the initial functional status. The assumed ongoing toxic and mechanical damaging impacts on the exposed neural placode are viewed as the “second hit”. The second hit presumably leads to additional deficits at and below the lesion level. These processes might also be responsible for further sequelae, like the development of secondary tethered cord syndrome (TCS), that typically occur during the later clinical course of the affected child. As in spinal cord injury (SCI), the second hit presumably induces further cellular and molecular lesion cascades in the placode, which are summarized under the term “third hit” (Figure 1A).
    Related Articles | Metrics
    A perspective on causality assessment in epigenetic research on neurodegenerative disorders
    Philippos Koulousakis, Assia Tiane, Niels Hellings, Jos Prickaerts, Daniel van den Hove, Tim Vanmierlo
    2023, 18 (2):  331-332.  doi: 10.4103/1673-5374.343898
    Abstract ( 163 )   PDF (396KB) ( 84 )   Save
    Epigenetics refers to heritable and reversible processes regulating gene expression that do not involve a change to the DNA sequence. Epigenetic modifications include DNA modifications (e.g. DNA methylation and hydroxymethylation), histone modifications, and non-coding RNAs such as micro RNAs and long-coding RNAs (Holtzman and Gersbach, 2018). Amongst others, epigenetic mechanisms play a vital role in cell proliferation and development, to ensure the correct genes are being expressed in a differentiating cell type. However, epigenetic mechanisms are also influenced by environmental cues, where they are subject to change during life, and may even mediate transgenerational inheritance (John and Rougeulle, 2018). In the last decades, research on epigenetics has expanded to study the role of these mechanisms in a plethora of diseases, such as neurodegenerative disorders (Lardenoije et al., 2018).
    Related Articles | Metrics
    On the interaction of a donepezil-huprine hybrid with synthetic membrane models
    Pablo Zambrano
    2023, 18 (2):  333-334.  doi: 10.4103/1673-5374.343903
    Abstract ( 123 )   PDF (298KB) ( 40 )   Save
    Alzheimer’s disease is the most prevalent type of dementia today, discovered and described by Alois Alzheimer in 1907. According to the World Alzheimer Report 2021, 75% of people with dementia worldwide are undiagnosed, equivalent to 41 million people (Gauthier et al., 2021). With each passing year, the number of people affected by these diseases is increasing, and the estimates of suffering from them in the future are growing. There are currently only four drugs used against Alzheimer’s disease: donepezil, rivastigmine, galantamine, and memantine. The first three, based on the cholinergic hypothesis, aim to inhibit the acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) to prevent the reduction of acetylcholine levels in the brain. Memantine, on the other hand, is based on the glutamatergic hypothesis, according to which in Alzheimer’s disease there are higher than normal levels of glutamate which, through interaction with the glutamatergic N-methyl-D-aspartate receptor, lead to abnormally high levels of calcium which cause neuronal damage. Blocking N-methyl-D-aspartate receptors to reduce these calcium levels is a therapeutic target to control this disease, and this is the mechanism of action of memantine (Rubin, 2021). Recently, the drug Aducanumab has also been approved in the United States. This is a human IgG1 monoclonal antibody that primarily binds to amyloid-beta (Aβ) aggregates, soluble oligomers, and also insoluble fibrils, limiting the toxicity of these species.
    Related Articles | Metrics
    Microtubule affinity regulating kinase (MARK/Par1) isoforms differentially regulate Alzheimer-like TAU missorting and Aβ-mediated synapse pathology
    Jana Chudobová, Hans Zempel
    2023, 18 (2):  335-336.  doi: 10.4103/1673-5374.346477
    Abstract ( 147 )   PDF (1503KB) ( 64 )   Save
    Importance of TAU protein for dementia syndromes: Dementia currently affects about 55 million people worldwide, with Alzheimer´s disease (AD) being the most prevalent form. The one crucial pathological hallmark of AD that correlates best with loss of synapses and cognitive decline are the so-called intracellular neurofibrillary tangles composed of mislocalized/missorted and hyperphosphorylated TAU protein (Naseri et al., 2019). Many other neurodegenerative diseases, both genetic and non-genetic, are characterized by neurofibrillary tangles or pathological accumulation of the protein TAU and are thus termed “tauopathies”. Tauopathies include AD and related aging-associated dementia syndromes like frontotemporal dementia and variants thereof (progressive supranuclear palsy, Pick‘s disease, corticobasal degeneration), but also childhood-onset genetic diseases (Zimmer-Bensch and Zempel, 2021).
    Related Articles | Metrics
    Apoptotic retinal ganglion cell loss is accompanied by complement and cytokine response in the βB1-CTGF primary open-angle glaucoma mouse model
    Ana Maria Mueller-Buehl, Sabrina Reinehr
    2023, 18 (2):  337-338.  doi: 10.4103/1673-5374.343911
    Abstract ( 108 )   PDF (3351KB) ( 41 )   Save
    Glaucoma is a multifactorial disease and occurs in many different species. In humans, glaucoma is accounted one of the leading causes for blindness worldwide. Due to glaucoma’s complexity, it is still unclear what pathomechanisms may be involved in its development in humans as well as in other species, such as canines. Diagnosis of glaucoma can be delayed because patients often do not notice a visual field loss until approximately 30% of retinal ganglion cells (RGCs) are lost (Kerrigan-Baumrind et al., 2000). Although the exact undergoing pathomechanisms of glaucoma disease are not fully understood yet, an increased intraocular pressure (IOP) is related to RGC death and is considered the main risk factor. To understand the underlying mechanisms more precisely, appropriate animal models are needed. For glaucoma research, many ocular hypertension models are available. In most of them, elevated IOP is introduced though surgical interventions, like injection of microbeads, laser coagulation, or cauterization of episcleral veins (Dey et al., 2018). Further, the most used genetic ocular hypertension model, the DBA2/J mouse, reflects more the secondary pigment dispersion glaucoma form rather than primary open-angle glaucoma (POAG; John et al., 1998). Hence, an ocular hypertension glaucoma model, which mimics POAG and does not need a surgical induction is of great interest for researchers.
    Related Articles | Metrics
    Potential role of PANoptosis in neuronal cell death: commentary on “PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons”
    Yanyan Sun, Changlian Zhu
    2023, 18 (2):  339-340.  doi: 10.4103/1673-5374.346483
    Abstract ( 254 )   PDF (1496KB) ( 150 )   Save
    Extensive neuronal cell death occurs during nervous system development to remove surplus, unwanted, and damaged cells. This is a highly regulated physiological process that plays a pivotal role in nervous system homeostasis and normal development. In some brain regions, more than half of the neurons are removed during normal development without interfering with the remaining cells. This gene-regulated neuronal cell deletion process is called programmed cell death (Fricker et al., 2018). However, under pathological conditions such as brain ischemia or hemorrhage and neurodegenerative and neuroinflammatory disorders, neuronal cell death may occur through gene-regulated cell death or accidental cell death in specific brain regions depending on the severity of the pathological stimuli. Accidental cell death is an uncontrolled or unavoidable biological process that involves immediate breakdown of cellular structures resulting from severe physiochemical or mechanical insult. Regulated cell death is closely integrated with signaling cascades and molecular processes that can be altered by pharmacological or genetic interventions (Cui et al., 2021).
    Related Articles | Metrics
    Commentary on “PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons”
    Macarena S. Arrázola, Felipe A. Court
    2023, 18 (2):  341.  doi: 10.4103/1673-5374.346543
    Abstract ( 133 )   PDF (276KB) ( 73 )   Save
    Several decades have passed since programmed-cell death (PCD) was identified. Apoptosis was first defined by Kerr in 1972, and later described by the Nobel Prices in Physiology or Medicine 2002, Sydney Brenner, John Sulston and Robert Horwitz, who defined genetic regulators of apoptosis (Diamantis et al., 2008). However, it was in 1858 when the German pathologist and biologist Rudolf Virchow identified for the first time the phenomenon of apoptosis, which he named necrobiosis, arguing that this form of cell death was completely different from the uncontrolled necrosis, suggesting the existence of two different types of cell death. Today, the knowledge in the field of cell death regulation is extensive, but still under continuous expansion.
    Related Articles | Metrics
    PANoptosis: new insights in regulated cell death in ischemia/reperfusion models
    Paloma González-Rodríguez, Arsenio Fernández-López
    2023, 18 (2):  342-343.  doi: 10.4103/1673-5374.343910
    Abstract ( 119 )   PDF (496KB) ( 96 )   Save
    The first study describing the cell death and destruction of tissues, organs, and organ systems as programmed events during the development of multicellular organisms was performed by JW Saunders Jr in 1966. The term apoptosis was introduced by Kerr, Wyllie, and Currie in 1972 to describe a programmed phenomenon opposite to mitosis in the regulation of animal cell populations. Later, a description of ectodermal cell lineages as programmed cell death in the worm Caenorhabditis elegans was published by JE Sulston and HR Horvitz in 1976. These studies led to exponential growth into the research of cell death, which revealed many different types of death. The complexity of cell death led to the formation of the Nomenclature Committee on Cell Death (NCCD) to standardize the criteria and define the different types of death. The most recent NCCD guideline, published in 2018, has updated the criteria necessary for defining and interpreting cell death, including morphological, biochemical, and functional perspectives (Galluzzi et al., 2018). In 2012, the NCCD proposed classifying cell death based on quantifiable biochemical parameters instead of the classic morphologic criteria and suggested using the specific terms of cell death subroutines. Since defining cell death is essential, some criteria of cell death were abandoned, for example, the engulfment of a cell which can, in some cases, preserve its viability. In 2015, the NCCD recommended only using two criteria to describe cell death: irreversible plasma membrane permeabilization and complete fragmentation. The NCCD recently redefined the term regulated cell death (RCD) to include the types of death that involve genetically encoded molecular machinery, which can be altered by pharmacological or genetic interventions. This is in contrast to accidental cell death, represented by the instantaneous and catastrophic demise of cells as a consequence of chemical (e.g., extreme pH) or physical (high pressure, temperature, shear stress) insults. The NCCD also defined programmed cell death as only the RCD in physiologic instances. Currently, the NCCD has designated the following cell death subroutines: intrinsic apoptosis, extrinsic apoptosis, mitochondrial permeability transition-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell death, neutrophil extracellular trap otic cell death, lysosome-dependent cell death, autophagy-dependent cell death, immunogenic cell death, cellular senescence, and mitotic catastrophe (Galluzzi et al., 2018).
    Related Articles | Metrics
    A novel aged mouse model of recurrent intracerebral hemorrhage in the bilateral striatum
    Li-Min Wang, Zhi-Hua Liu, Hong-Lei Ren, Xue-Mei Chen, Jun-Min Wang, Hui-Min Cai, Li-Ping Wei, Hui-Hong Tian, Jian Wang, Li-Juan Wang
    2023, 18 (2):  344-349.  doi: 10.4103/1673-5374.346459
    Abstract ( 134 )   PDF (1688KB) ( 54 )   Save
    The current animal models of stroke primarily model a single intracerebral hemorrhage (ICH) attack, and there is a lack of a reliable model of recurrent ICH. In this study, we established 16-month-old C57BL/6 male mouse models of ICH by injecting collagenase VII-S into the left striatum. Twenty-one days later, we injected collagenase VII-S into the right striatum to simulate recurrent ICH. Our results showed that mice subjected to bilateral striatal hemorrhage had poorer neurological function at the early stage of hemorrhage, delayed recovery in locomotor function, motor coordination, and movement speed, and more obvious emotional and cognitive dysfunction than mice subjected to unilateral striatal hemorrhage. These findings indicate that mouse models of bilateral striatal hemorrhage can well simulate clinically common recurrent ICH. These models should be used as a novel tool for investigating the pathogenesis and treatment targets of recurrent ICH.
    Related Articles | Metrics
    Knockout of Sirt2 alleviates traumatic brain injury in mice
    Wei Wang, Qiu-Yuan Gong, Lin Cai, Yao Jing, Dian-Xu Yang, Fang Yuan, Hao Chen, Heng-Li Tian
    2023, 18 (2):  350-356.  doi: 10.4103/1673-5374.346457
    Abstract ( 140 )   PDF (3646KB) ( 84 )   Save
    Sirtuin 2 (SIRT2) inhibition or Sirt2 knockout in animal models protects against the development of neurodegenerative diseases and cerebral ischemia. However, the role of SIRT2 in traumatic brain injury (TBI) remains unclear. In this study, we found that knockout of Sirt2 in a mouse model of TBI reduced brain edema, attenuated disruption of the blood-brain barrier, decreased expression of the nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome, reduced the activity of the effector caspase-1, reduced neuroinflammation and neuronal pyroptosis, and improved neurological function. Knockout of Sirt2 in a mechanical stretch injury cell model in vitro also decreased expression of the NLRP3 inflammasome and pyroptosis. Our findings suggest that knockout of Sirt2 is neuroprotective against TBI; therefore, Sirt2 could be a novel target for TBI treatment. 
    Related Articles | Metrics
    PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons
    Wei-Tao Yan, Wen-Juan Zhao, Xi-Min Hu, Xiao-Xia Ban, Wen-Ya Ning, Hao Wan, Qi Zhang, Kun Xiong
    2023, 18 (2):  357-363.  doi: 10.4103/1673-5374.346545
    Abstract ( 280 )   PDF (10070KB) ( 76 )   Save
    PANoptosis is a newly identified type of regulated cell death that consists of pyroptosis, apoptosis, and necroptosis, which simultaneously occur during the pathophysiological process of infectious and inflammatory diseases. Although our previous literature mining study suggested that PANoptosis might occur in neuronal ischemia/reperfusion injury, little experimental research has been reported on the existence of PANoptosis. In this study, we used in vivo and in vitro retinal neuronal models of ischemia/reperfusion injury to investigate whether PANoptosis-like cell death (simultaneous occurrence of pyroptosis, apoptosis, and necroptosis) exists in retinal neuronal ischemia/reperfusion injury. Our results showed that ischemia/reperfusion injury induced changes in morphological features and protein levels that indicate PANoptosis-like cell death in retinal neurons both in vitro and in vivo. Ischemia/reperfusion injury also significantly upregulated caspase-1, caspase-8, and NLRP3 expression, which are important components of the PANoptosome. These results indicate the existence of PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons and provide preliminary experimental evidence for future study of this new type of regulated cell death.
    Related Articles | Metrics
    Nicotinic acetylcholine signaling is required for motor learning but not for rehabilitation from spinal cord injury
    Yue Li, Edmund R. Hollis II
    2023, 18 (2):  364-367.  doi: 10.4103/1673-5374.346544
    Abstract ( 146 )   PDF (1073KB) ( 66 )   Save
    Therapeutic intervention for spinal cord injury is limited, with many approaches relying on strengthening the remaining substrate and driving recovery through rehabilitative training. As compared with learning novel compensatory strategies, rehabilitation focuses on restoring movements lost to injury. Whether rehabilitation of previously learned movements after spinal cord injury requires the molecular mechanisms of motor learning, or if it engages previously trained motor circuits without requiring novel learning remains an open question. In this study, mice were randomly assigned to receive intraperitoneal injection with the pan-nicotinic, non-competitive antagonist mecamylamine and the nicotinic α7 subunit selective antagonist methyllycaconitine citrate salt or vehicle (normal saline) prior to motor learning assays, then randomly reassigned after motor learning for rehabilitation study post-injury. Cervical spinal cord dorsal column lesion was used as a model of incomplete injury. Results of this study showed that nicotinic acetylcholine signaling was required for motor learning of the single pellet-reaching task but it was dispensable for the rehabilitation of the same task after injury. Our findings indicate that critical differences exist between the molecular mechanisms supporting compensatory motor learning strategies and the restoration of behavior lost to spinal cord injury.
    Related Articles | Metrics
    Repetitive transcranial magnetic stimulation promotes neurological functional recovery in rats with traumatic brain injury by upregulating synaptic plasticity-related proteins
    Fang-Fang Qian, You-Hua He, Xiao-Hui Du, Hua-Xiang Lu, Ren-Hong He, Jian-Zhong Fan
    2023, 18 (2):  368-374.  doi: 10.4103/1673-5374.346548
    Abstract ( 182 )   PDF (8862KB) ( 57 )   Save
    Studies have shown that repetitive transcranial magnetic stimulation (rTMS) can enhance synaptic plasticity and improve neurological dysfunction. However, the mechanism through which rTMS can improve moderate traumatic brain injury remains poorly understood. In this study, we established rat models of moderate traumatic brain injury using Feeney’s weight-dropping method and treated them using rTMS. To help determine the mechanism of action, we measured levels of several important brain activity-related proteins and their mRNA. On the injured side of the brain, we found that rTMS increased the protein levels and mRNA expression of brain-derived neurotrophic factor, tropomyosin receptor kinase B, N-methyl-D-aspartic acid receptor 1, and phosphorylated cAMP response element binding protein, which are closely associated with the occurrence of long-term potentiation. rTMS also partially reversed the loss of synaptophysin after injury and promoted the remodeling of synaptic ultrastructure. These findings suggest that upregulation of synaptic plasticity-related protein expression is the mechanism through which rTMS promotes neurological function recovery after moderate traumatic brain injury. 
    Related Articles | Metrics
    Platelet-rich plasma promotes peripheral nerve regeneration after sciatic nerve injury
    Su-Long Wang, Xi-Lin Liu, Zhi-Chen Kang, Yue-Shu Wang
    2023, 18 (2):  375-381.  doi: 10.4103/1673-5374.346461
    Abstract ( 156 )   PDF (4201KB) ( 52 )   Save
    The effect of platelet-rich plasma on nerve regeneration remains controversial. In this study, we established a rabbit model of sciatic nerve small-gap defects with preserved epineurium and then filled the gaps with platelet-rich plasma. Twenty-eight rabbits were divided into the following groups (7 rabbits/group): model, low-concentration PRP (2.5–3.5-fold concentration of whole blood platelets), medium-concentration PRP (4.5–6.5-fold concentration of whole blood platelets), and high-concentration PRP (7.5–8.5-fold concentration of whole blood platelets). Electrophysiological and histomorphometrical assessments and proteomics analysis were used to evaluate regeneration of the sciatic nerve. Our results showed that platelet-rich plasma containing 4.5–6.5- and 7.5–8.5-fold concentrations of whole blood platelets promoted repair of sciatic nerve injury. Proteomics analysis was performed to investigate the possible mechanism by which platelet-rich plasma promoted nerve regeneration. Proteomics analysis showed that after sciatic nerve injury, platelet-rich plasma increased the expression of integrin subunit β-8 (ITGB8), which participates in angiogenesis, and differentially expressed proteins were mainly enriched in focal adhesion pathways. Additionally, two key proteins, ribosomal protein S27a (RSP27a) and ubiquilin 1 (UBQLN1), which were selected after protein-protein interaction analysis, are involved in the regulation of ubiquitin levels in vivo. These data suggest that platelet-rich plasma promotes peripheral nerve regeneration after sciatic nerve injury by affecting angiogenesis and intracellular ubiquitin levels. 
    Related Articles | Metrics
    Neuroprotective effects of exogenous brain-derived neurotrophic factor on amyloid-beta 1–40-induced retinal degeneration
    Mohd Aizuddin Mohd Lazaldin, Igor Iezhitsa, Renu Agarwal, Puneet Agarwal, Nafeeza Mohd Ismail
    2023, 18 (2):  382-388.  doi: 10.4103/1673-5374.346546
    Abstract ( 140 )   PDF (1502KB) ( 71 )   Save
    Amyloid-beta (Aβ)-related alterations, similar to those found in the brains of patients with Alzheimer’s disease, have been observed in the retina of patients with glaucoma. Decreased levels of brain-derived neurotrophic factor (BDNF) are believed to be associated with the neurotoxic effects of Aβ peptide. To investigate the mechanism underlying the neuroprotective effects of BDNF on Aβ1–40-induced retinal injury in Sprague-Dawley rats, we treated rats by intravitreal administration of phosphate-buffered saline (control), Aβ1–40 (5 nM), or Aβ1–40 (5 nM) combined with BDNF (1 µg/mL). We found that intravitreal administration of Aβ1–40 induced retinal ganglion cell apoptosis. Fluoro-Gold staining showed a significantly lower number of retinal ganglion cells in the Aβ1–40 group than in the control and BDNF groups. In the Aβ1–40 group, low number of RGCs was associated with increased caspase-3 expression and reduced TrkB and ERK1/2 expression. BDNF abolished Aβ1–40-induced increase in the expression of caspase-3 at the gene and protein levels in the retina and upregulated TrkB and ERK1/2 expression. These findings suggest that treatment with BDNF prevents RGC apoptosis induced by Aβ1–40 by activating the BDNF-TrkB signaling pathway in rats.
    Related Articles | Metrics
    β-Estradiol 17-acetate enhances the in vitro vitality of endothelial cells isolated from the brain of patients subjected to neurosurgery
    Sonia Guzzo, Pasquale De Bonis, Barbara Pavan, Luciano Fadiga
    2023, 18 (2):  389-395.  doi: 10.4103/1673-5374.346054
    Abstract ( 143 )   PDF (7047KB) ( 26 )   Save
    In the current landscape of endothelial cell isolation for building in vitro models of the blood-brain barrier, our work moves towards reproducing the features of the neurovascular unit to achieve glial compliance through an innovative biomimetic coating technology for brain chronic implants. We hypothesized that the autologous origin of human brain microvascular endothelial cells (hBMECs) is the first requirement for the suitable coating to prevent the glial inflammatory response triggered by foreign neuroprosthetics. Therefore, this study established a new procedure to preserve the in vitro viability of hBMECs isolated from gray and white matter specimens taken from neurosurgery patients. Culturing adult hBMECs is generally considered a challenging task due to the difficult survival ex vivo and progressive reduction in proliferation of these cells. The addition of 10 nM β-estradiol 17-acetate to the hBMEC culture medium was found to be an essential and discriminating factor promoting adhesion and proliferation both after isolation and thawing, supporting the well-known protective role played by estrogens on microvessels. In particular, β-estradiol 17-acetate was critical for both freshly isolated and thawed female-derived hBMECs, while it was not necessary for freshly isolated male-derived hBMECs; however, it did counteract the decay in the viability of the latter after thawing. The tumor-free hBMECs were thus cultured for up to 2 months and their growth efficiency was assessed before and after two periods of cryopreservation. Despite the thermal stress, the hBMECs remained viable and suitable for re-freezing and storage for several months. This approach increasing in vitro viability of hBMECs opens new perspectives for the use of cryopreserved autologous hBMECs as biomimetic therapeutic tools, offering the potential to avoid additional surgical sampling for each patient. 
    Related Articles | Metrics
    Knockdown of polypyrimidine tract binding protein facilitates motor function recovery after spinal cord injury
    Ri-Yun Yang, Rui Chai, Jing-Ying Pan, Jing-Yin Bao, Pan-Hui Xia, Yan-Kai Wang, Ying Chen, Yi Li, Jian Wu, Gang Chen
    2023, 18 (2):  396-403.  doi: 10.4103/1673-5374.346463
    Abstract ( 163 )   PDF (9158KB) ( 52 )   Save
    After spinal cord injury (SCI), a fibroblast- and microglia-mediated fibrotic scar is formed in the lesion core, and a glial scar is formed around the fibrotic scar as a result of the activation and proliferation of astrocytes. Simultaneously, a large number of neurons are lost in the injured area. Regulating the dense glial scar and replenishing neurons in the injured area are essential for SCI repair. Polypyrimidine tract binding protein (PTB), known as an RNA-binding protein, plays a key role in neurogenesis. Here, we utilized short hairpin RNAs (shRNAs) and antisense oligonucleotides (ASOs) to knock down PTB expression. We found that reactive spinal astrocytes from mice were directly reprogrammed into motoneuron-like cells by PTB downregulation in vitro. In a mouse model of compression-induced SCI, adeno-associated viral shRNA-mediated PTB knockdown replenished motoneuron-like cells around the injured area. Basso Mouse Scale scores and forced swim, inclined plate, cold allodynia, and hot plate tests showed that PTB knockdown promoted motor function recovery in mice but did not improve sensory perception after SCI. Furthermore, ASO-mediated PTB knockdown improved motor function restoration by not only replenishing motoneuron-like cells around the injured area but also by modestly reducing the density of the glial scar without disrupting its overall structure. Together, these findings suggest that PTB knockdown may be a promising therapeutic strategy to promote motor function recovery during spinal cord repair.
    Related Articles | Metrics
    Neural stem cell-derived exosome as a nano-sized carrier for BDNF delivery to a rat model of ischemic stroke
    Zhi-Han Zhu, Feng Jia, Waqas Ahmed, Gui-Long Zhang, Hong Wang, Chao-Qun Lin, Wang-Hao Chen, Lu-Kui Chen
    2023, 18 (2):  404-409.  doi: 10.4103/1673-5374.346466
    Abstract ( 299 )   PDF (4785KB) ( 120 )   Save
    Our previous study demonstrated the potential therapeutic role of human neural stem cell-derived exosomes (hNSC-Exo) in ischemic stroke. Here, we loaded brain-derived neurotrophic factor (BDNF) into exosomes derived from NSCs to construct engineered exosomes (BDNF-hNSC-Exo) and compared their effects with those of hNSC-Exo on ischemic stroke both in vitro and in vivo. In a model of H2O2-induced oxidative stress in NSCs, BDNF-hNSC-Exo markedly enhanced cell survival. In a rat middle cerebral artery occlusion model, BDNF-hNSC-Exo not only inhibited the activation of microglia, but also promoted the differentiation of endogenous NSCs into neurons. These results suggest that BDNF can improve the function of NSC-derived exosomes in the treatment of ischemic stroke. Our research may support the clinical use of other neurotrophic factors for central nervous system diseases.
    Related Articles | Metrics
    Modified constraint-induced movement therapy enhances cortical plasticity in a rat model of traumatic brain injury: a resting-state functional MRI study
    Cheng-Cheng Sun, Yu-Wen Zhang, Xiang-Xin Xing, Qi Yang, Ling-Yun Cao, Yu-Feng Cheng, Jing-Wang Zhao, Shao-Ting Zhou, Dan-Dan Cheng, Ye Zhang, Xu-Yun Hua, He Wang, Dong-Sheng Xu
    2023, 18 (2):  410-415.  doi: 10.4103/1673-5374.344832
    Abstract ( 143 )   PDF (3043KB) ( 80 )   Save
    Modified constraint-induced movement therapy (mCIMT) has shown beneficial effects on motor function improvement after brain injury, but the exact mechanism remains unclear. In this study, amplitude of low frequency fluctuation (ALFF) metrics measured by resting-state functional magnetic resonance imaging was obtained to investigate the efficacy and mechanism of mCIMT in a control cortical impact (CCI) rat model simulating traumatic brain injury. At 3 days after control cortical impact model establishment, we found that the mean ALFF (mALFF) signals were decreased in the left motor cortex, somatosensory cortex, insula cortex and the right motor cortex, and were increased in the right corpus callosum. After 3 weeks of an 8-hour daily mCIMT treatment, the mALFF values were significantly increased in the bilateral hemispheres compared with those at 3 days postoperatively. The mALFF signal values of left corpus callosum, left somatosensory cortex, right medial prefrontal cortex, right motor cortex, left postero dorsal hippocampus, left motor cortex, right corpus callosum, and right somatosensory cortex were increased in the mCIMT group compared with the control cortical impact group. Finally, we identified brain regions with significantly decreased mALFF values at 3 days postoperatively. Pearson correlation coefficients with the right forelimb sliding score indicated that the improvement in motor function of the affected upper limb was associated with an increase in mALFF values in these brain regions. Our findings suggest that functional cortical plasticity changes after brain injury, and that mCIMT is an effective method to improve affected upper limb motor function by promoting bilateral hemispheric cortical remodeling. mALFF values correlate with behavioral changes and can potentially be used as biomarkers to assess dynamic cortical plasticity after traumatic brain injury.
    Related Articles | Metrics
    Treatment of radiation-induced brain injury with bisdemethoxycurcumin
    Yun-Qian Chang, Gui-Juan Zhou, Hong-Mei Wen, Duan-Qun He, Chen-Lin Xu, Ya-Rui Chen, Yi-Hui Li, Shuang-Xi Chen, Zi-Jian Xiao, , Ming Xie,
    2023, 18 (2):  416-421.  doi: 10.4103/1673-5374.346549
    Abstract ( 183 )   PDF (7755KB) ( 47 )   Save
    Radiation therapy is considered the most effective non-surgical treatment for brain tumors. However, there are no available treatments for radiation-induced brain injury. Bisdemethoxycurcumin (BDMC) is a demethoxy derivative of curcumin that has anti-proliferative, anti-inflammatory, and anti-oxidant properties. To determine whether BDMC has the potential to treat radiation-induced brain injury, in this study, we established a rat model of radiation-induced brain injury by administering a single 30-Gy vertical dose of irradiation to the whole brain, followed by intraperitoneal injection of 500 μL of a 100 mg/kg BDMC solution every day for 5 successive weeks. Our results showed that BDMC increased the body weight of rats with radiation-induced brain injury, improved learning and memory, attenuated brain edema, inhibited astrocyte activation, and reduced oxidative stress. These findings suggest that BDMC protects against radiation-induced brain injury.
    Related Articles | Metrics
    Identification of injury type using somatosensory and motor evoked potentials in a rat spinal cord injury model
    Rong Li, Han-Lei Li, Hong-Yan Cui, Yong-Can Huang, Yong Hu
    2023, 18 (2):  422-427.  doi: 10.4103/1673-5374.346458
    Abstract ( 142 )   PDF (3820KB) ( 79 )   Save
    The spinal cord is at risk of injury during spinal surgery. If intraoperative spinal cord injury is identified early, irreversible impairment or loss of neurological function can be prevented. Different types of spinal cord injury result in damage to different spinal cord regions, which may cause different somatosensory and motor evoked potential signal responses. In this study, we examined electrophysiological and histopathological changes between contusion, distraction, and dislocation spinal cord injuries in a rat model. We found that contusion led to the most severe dorsal white matter injury and caused considerable attenuation of both somatosensory and motor evoked potentials. Dislocation resulted in loss of myelinated axons in the lateral region of the injured spinal cord along the rostrocaudal axis. The amplitude of attenuation in motor evoked potential responses caused by dislocation was greater than that caused by contusion. After distraction injury, extracellular spaces were slightly but not significantly enlarged; somatosensory evoked potential responses slightly decreased and motor evoked potential responses were lost. Correlation analysis showed that histological and electrophysiological findings were significantly correlated and related to injury type. Intraoperative monitoring of both somatosensory and motor evoked potentials has the potential to identify iatrogenic spinal cord injury type during surgery.
    Related Articles | Metrics
    Effects of C2 hemisection on respiratory and cardiovascular functions in rats
    Pauline Michel-Flutot, Arnaud Mansart, Abdallah Fayssoil, Stéphane Vinit
    2023, 18 (2):  428-433.  doi: 10.4103/1673-5374.346469
    Abstract ( 191 )   PDF (2295KB) ( 74 )   Save
    High cervical spinal cord injuries induce permanent neuromotor and autonomic deficits. These injuries impact both central respiratory and cardiovascular functions through modulation of the sympathetic nervous system. So far, cardiovascular studies have focused on models of complete contusion or transection at the lower cervical and thoracic levels and diaphragm activity evaluations using invasive methods. The present study aimed to evaluate the impact of C2 hemisection on different parameters representing vital functions (i.e., respiratory function, cardiovascular, and renal filtration parameters) at the moment of injury and 7 days post-injury in rats. No ventilatory parameters evaluated by plethysmography were impacted during quiet breathing after 7 days post-injury, whereas permanent diaphragm hemiplegia was observed by ultrasound and confirmed by diaphragmatic electromyography in anesthetized rats. Interestingly, the mean arterial pressure was reduced immediately after C2 hemisection, with complete compensation at 7 days post-injury. Renal filtration was unaffected at 7 days post-injury; however, remnant systolic dysfunction characterized by a reduced left ventricular ejection fraction persisted at 7 days post-injury. Taken together, these results demonstrated that following C2 hemisection, diaphragm activity and systolic function are impacted up to 7 days post-injury, whereas the respiratory and cardiovascular systems display vast adaptation to maintain ventilatory parameters and blood pressure homeostasis, with the latter likely sustained by the remaining descending sympathetic inputs spared by the initial injury. A better broad characterization of the physiopathology of high cervical spinal cord injuries covering a longer time period post-injury could be beneficial for understanding evaluations of putative therapeutics to further increase cardiorespiratory recovery. 
    Related Articles | Metrics
    The Alzheimer’s disease-associated gene TREML2 modulates inflammation by regulating microglia polarization and NLRP3 inflammasome activation
    Si-Yu Wang, Xin-Xin Fu, Rui Duan, Bin Wei, Hai-Ming Cao, Yan E, Shuai-Yu Chen, Ying-Dong Zhang, Teng Jiang
    2023, 18 (2):  434-438.  doi: 10.4103/1673-5374.346468
    Abstract ( 273 )   PDF (1491KB) ( 64 )   Save
    Triggering receptor expressed on myeloid cells-like 2 (TREML2) is a newly identified susceptibility gene for Alzheimer’s disease (AD). It encodes a microglial inflammation-associated receptor. To date, the potential role of microglial TREML2 in neuroinflammation in the context of AD remains unclear. In this study, APP/PS1 mice were used to investigate the dynamic changes of TREML2 levels in brain during AD progression. In addition, lipopolysaccharide (LPS)  stimulation of primary microglia as well as a lentivirus-mediated TREML2 overexpression and knockdown were employed to explore the role of TREML2 in neuroinflammation in the context of AD. Our results show that TREML2 levels gradually increased in the brains of APP/PS1 mice during disease progression. LPS stimulation of primary microglia led to the release of inflammatory cytokines including interleukin-1β, interleukin-6, and tumor necrosis factor-α in the culture medium. The LPS-induced microglial release of inflammatory cytokines was enhanced by TREML2 overexpression and was attenuated by TREML2 knockdown. LPS increased the levels of microglial M1-type polarization marker inducible nitric oxide synthase. This effect was enhanced by TREML2 overexpression and ameliorated by TREML2 knockdown. Furthermore, the levels of microglial M2-type polarization markers CD206 and ARG1 in the primary microglia were reduced by TREML2 overexpression and elevated by TREML2 knockdown. LPS stimulation increased the levels of NLRP3 in primary microglia. The LPS-induced increase in NLRP3 was further elevated by TREML2 overexpression and alleviated by TREML2 knockdown. In summary, this study provides the first evidence that TREML2 modulates inflammation by regulating microglial polarization and NLRP3 inflammasome activation. These findings reveal the mechanisms by which TREML2 regulates microglial inflammation and suggest that TREML2 inhibition may represent a novel therapeutic strategy for AD. 
    Related Articles | Metrics
    Functional recovery and muscle atrophy in pre-clinical models of peripheral nerve transection and gap-grafting in mice: effects of 4-aminopyridine
    Jung Il Lee, M A Hassan Talukder, Zara Karuman, Anagha A. Gurjar, Prem Kumar Govindappa, Jagadeeshaprasad M. Guddadarangaiah, Kristen M. Manto, Grant D. Wandling, John P. Hegarty, David L. Waning, John C. Elfar
    2023, 18 (2):  439-444.  doi: 10.4103/1673-5374.346456
    Abstract ( 120 )   PDF (6411KB) ( 56 )   Save
    We recently demonstrated a repurposing beneficial effect of 4-aminopyridine (4-AP), a potassium channel blocker, on functional recovery and muscle atrophy after sciatic nerve crush injury in rodents. However, this effect of 4-AP is unknown in nerve transection, gap, and grafting models. To evaluate and compare the functional recovery, nerve morphology, and muscle atrophy, we used a novel stepwise nerve transection with gluing (STG), as well as 7-mm irreparable nerve gap (G-7/0) and 7-mm isografting in 5-mm gap (G-5/7) models in the absence and presence of 4-AP treatment. Following surgery, sciatic functional index was determined weekly to evaluate the direct in vivo global motor functional recovery. After 12 weeks, nerves were processed for whole-mount immunofluorescence imaging, and tibialis anterior muscles were harvested for wet weight and quantitative histomorphological analyses for muscle fiber cross-sectional area and minimal Feret’s diameter. Average post-injury sciatic functional index values in STG and G-5/7 models were significantly greater than those in the G-7/0 model. 4-AP did not affect the sciatic functional index recovery in any model. Compared to STG, nerve imaging revealed more misdirected axons and distorted nerve architecture with isografting. While muscle weight, cross-sectional area, and minimal Feret’s diameter were significantly smaller in G-7/0 model compared with STG and G-5/7, 4-AP treatment significantly increased right TA muscle mass, cross-sectional area, and minimal Feret’s diameter in G-7/0 model. These findings demonstrate that functional recovery and muscle atrophy after peripheral nerve injury are directly related to the intervening nerve gap, and 4-AP exerts differential effects on functional recovery and muscle atrophy.
    Related Articles | Metrics
    Sox11b regulates the migration and fate determination of Müller glia-derived progenitors during retina regeneration in zebrafish
    Kaida Song, Zihao Lin, Lining Cao, Bowen Lu, Yuxi Chen, Shuqiang Zhang, Jianfeng Lu, Hui Xu
    2023, 18 (2):  445-450.  doi: 10.4103/1673-5374.346550
    Abstract ( 181 )   PDF (3425KB) ( 74 )   Save
    The transcription factor Sox11 plays important roles in retinal neurogenesis during vertebrate eye development. However, its function in retina regeneration remains elusive. Here we report that Sox11b, a zebrafish Sox11 homolog, regulates the migration and fate determination of Müller glia-derived progenitors (MGPCs) in an adult zebrafish model of mechanical retinal injury. Following a stab injury, the expression of Sox11b was induced in proliferating MGPCs in the retina. Sox11b knockdown did not affect MGPC formation at 4 days post-injury, although the nuclear morphology and subsequent radial migration of MGPCs were altered. At 7 days post-injury, Sox11b knockdown resulted in an increased proportion of MGPCs in the inner retina and a decreased proportion of MGPCs in the outer nuclear layer, compared with controls. Furthermore, Sox11b knockdown led to reduced photoreceptor regeneration, while it increased the numbers of newborn amacrines and retinal ganglion cells. Finally, quantitative polymerase chain reaction analysis revealed that Sox11b regulated the expression of Notch signaling components in the retina, and Notch inhibition partially recapitulated the Sox11b knockdown phenotype, indicating that Notch signaling functions downstream of Sox11b. Our findings imply that Sox11b plays key roles in MGPC migration and fate determination during retina regeneration in zebrafish, which may have critical implications for future explorations of retinal repair in mammals.
    Related Articles | Metrics
    Anti-inflammatory effect of miR-125a-5p on experimental optic neuritis by promoting the differentiation of Treg cells
    Jia-Lin Zhan, Yan-Ling Huang, Qiao-Wen Liang, Xiao-Sheng Qu, Zi-Mei Dong, Yi Du, Wen-Jing Luo
    2023, 18 (2):  451-455.  doi: 10.4103/1673-5374.346462
    Abstract ( 150 )   PDF (7415KB) ( 35 )   Save
    Methylprednisolone pulse treatment is currently used for optic neuritis. It can speed visual recovery, but does not improve the ultimate visual outcomes. Recent studies have reported that miR-125a-5p has immunomodulatory effects on autoimmune diseases. However, it remains unclear whether miR-125a-5p has effects on optic neuritis. In this study, we used adeno-associated virus to overexpress or silence miR-125a-5p in mice. We found that silencing miR-125a-5p increased the latency of visual evoked potential and aggravated inflammation of the optic nerve. Overexpression of miR-125a-5p suppressed inflammation of the optic nerve, protected retinal ganglion cells, and increased the percentage of Treg cells. Our findings show that miR-125a-5p exhibits anti-inflammatory effects through promoting the differentiation of Treg cells.
    Related Articles | Metrics
    Intrathecal liproxstatin-1 delivery inhibits ferroptosis and attenuates mechanical and thermal hypersensitivities in rats with complete Freund’s adjuvant-induced inflammatory pain
    Yi-Fan Deng, Ping Xiang, Jing-Yi Du, Jian-Fen Liang, Xiang Li
    2023, 18 (2):  456-462.  doi: 10.4103/1673-5374.346547
    Abstract ( 290 )   PDF (24523KB) ( 71 )   Save
    Previous studies have confirmed the relationship between iron-dependent ferroptosis and a peripheral nerve injury-induced neuropathic pain model. However, the role of ferroptosis in inflammatory pain remains inconclusive. Therefore, we aimed to explore whether ferroptosis in the spinal cord and dorsal root ganglion contributes to complete Freund’s adjuvant (CFA)-induced painful behaviors in rats. Our results revealed that various biochemical and morphological changes were associated with ferroptosis in the spinal cord and dorsal root ganglion tissues of CFA rats. These changes included iron overload, enhanced lipid peroxidation, disorders of anti-acyl-coenzyme A synthetase long-chain family member 4 and glutathione peroxidase 4 levels, and abnormal morphological changes in mitochondria. Intrathecal treatment of liproxstatin-1 (a ferroptosis inhibitor) reversed these ferroptosis-related changes and alleviated mechanical and thermal hypersensitivities in CFA rats. Our study demonstrated the occurrence of ferroptosis in the spinal cord and dorsal root ganglion tissues in a rodent model of inflammatory pain and indicated that intrathecal administration of ferroptosis inhibitors, such as liproxstatin-1, is a potential therapeutic strategy for treating inflammatory pain.
    Related Articles | Metrics
    Emerging evidence of neuronal cells-targeting SARS-CoV-2 causing anosmia associated with COVID-19
    Abdul Mannan Baig
    2023, 18 (2):  463-464.  doi: 10.4103/1673-5374.344843
    Abstract ( 108 )   PDF (723KB) ( 50 )   Save
    The anosmia and hypogeusia that accompany the syndromic manifestations of coronavirus disease 2019 (COVID-19) have become an increasing area of research during the current pandemic. These deficits are experienced as a major concern and are found to compromise the lifestyle of patients during and after acute phase of COVID-19. The key issue is the prevalence of smell and taste disorders that have been reported in some patients after partial recovery from COVID-19. Very little is known about the exact mechanism underlying anosmia or parosmia in COVID-19. 
    Related Articles | Metrics